Featuring Key Players Abbott, Nova Biomedical, Trividia Health & More

DUBLIN, June 29, 2022 / PRNewswire / – The “Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report by Product (Accu-Chek Inform II, Freestyle Lite), by Region (North America, EuropeAPAC, LATAM, MEA), and Segment Forecasts, 2022-2030 “report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

The global point-of-care glucose testing market size is expected to reach USD 4.5 billion by 2030, growing at a CAGR of 4.1% over the forecast period. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years.

As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings.

The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market.

Point-of-Care Glucose Testing Market Report Highlights

  • Accu-Chek Inform II accounted for the largest revenue share in 2021 and is anticipated to maintain this trend throughout the forecast period.

  • Bayer Contour blood glucose monitoring system is set to grow at a CAGR of 6.1% from 2022 to 2030.

  • North America is the leading regional market due to the higher penetration of novel diagnostic techniques.

  • Asia Pacific is estimated to register the fastest CAGR owing to the ever-increasing prevalence of diabetes and numerous untapped growth opportunities in diagnostics.

  • Moreover, a robust network of local manufacturers has significantly contributed to the revenue generated in this region.

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Point-of-Care (POC) Glucose Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related / ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Introduction of CLIA waived tests
3.4.1.2. Growing prevalence of diabetes
3.4.1.3. Rising demand for short turnaround time glucose POC testing
3.4.2. Market restraint analysis
3.4.2.1. Potential interference and calibration issues in glucose meters
3.4.2.2. Presence of ambiguous regulatory as well as reimbursement framework
3.5. Point-of-Care (POC) Glucose Testing Market Analysis Tools
3.5.1. Industry Analysis-Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Point-of-Care (POC) Glucose Testing Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Accu-Check Aviva Meter
4.1.2. Onetouch Verio Flex
4.1.3. STAT
4.1.4. Freestyle Lite
4.1.5. Bayer CONTOUR Blood Glucose Monitoring System
4.1.6. True Metrix
4.1.7. Accu-Check Inform II
4.1.8. StatStrip
4.1.9. Others
4.2. Product Market Share, 2018 & 2030
4.3. Dashboard segment
4.4. Point-of-Care (POC) Glucose Testing Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyzes, 2018 to 2030 for the following
4.5.1. Accu-Check Aviva Meter
4.5.1.1. Accu-Check Aviva Meter market estimates and forecast, 2018-2030
4.5.2. Onetouch Verio Flex
4.5.2.1. Onetouch Verio Flex market estimates and forecast, 2018-2030
4.5.3. STAT
4.5.3.1. STAT market estimates and forecast, 2018-2030
4.5.4. Freestyle Lite
4.5.4.1. Freestyle Lite market estimates and forecast, 2018-2030
4.5.5. Bayer Contour Blood Glucose Monitoring System
4.5.5.1. Bayer Contour Blood Glucose Monitoring System market estimates and forecast, 2018-2030
4.5.6. True Metrix
4.5.6.1. TRUE METRIX market estimates and forecast, 2018-2030
4.5.7. Accu-Check Inform II
4.5.7.1. Accu-Check Inform II market estimates and forecast, 2018-2030
4.5.8. StatStrip
4.5.8.1. StatStrip market estimates and forecast, 2018-2030
4.5.9. Others
4.5.9.1. Others market estimates and forecast, 2018-2030

Chapter 5. Point-of-Care (POC) Glucose Testing Market: Regional Estimates & Trend Analysis

Chapter 6. Competitive Landscape

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.

  • Abbott

  • Nipro

  • PlatInium Equity Advisors, LLC (Lifescan, Inc.)

  • New Biomedical

  • ACON Laboratories

  • Trividia Health, Inc.

  • Prodigy Diabetes Care, LLC

  • Bayer AG / Ascensia Diabetes Care Holdings AG

  • EKF Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/77z0vw

Media Contact:

Research and Markets
Laura WoodSenior Manager
press@researchandmarkets.com

For EST Office Hours Call + 1-917-300-0470
For US / CAN Toll Free Call + 1-800-526-8630
For GMT Office Hours Call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside US): + 353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision

Cision

View original content: https: //www.prnewswire.com/news-releases/point-of-care-glucose-testing-market-report-2022-2030-featuring-key-players-abbott-nova-biomedical-trividia- health – more-301578102.html

SOURCE Research and Markets

Leave a Comment

Your email address will not be published.

%d bloggers like this: